Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine in Knee Arthroscopy
NCT05807945Phase 4Completed
- Start
- Apr 2020
- Primary completion
- Feb 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial of ropivacaine in acute pain (2 arms). Primary endpoint: Number of Participants With Acute Pain (Visual Analogue Scale) at 2 hours. Started Apr 2020; status: completed.
02
Drugs
ropivacaine
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT05807945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05807945.